DeepMed Research

Yuhan Corporation

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy Male Volunteer

Interventions: Drug: Telmisartan
Drug: Amlodipine
Drug: Rosuvastatin

First Posted Date: 2014-09-08

Last Posted Date: 2015-02-18

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 60

Registration Number: NCT02233218

Locations: 🇰🇷
Dong-A university hospital, Pusan, Korea, Republic of

The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: YH4808 NF 100
Drug: YH4808 OF 200
Drug: YH4808 NF 400
Drug: YH4808 NF 200

First Posted Date: 2014-06-27

Last Posted Date: 2022-01-13

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 82

Registration Number: NCT02176668

Locations: 🇰🇷
Yonsei Medical Center Severance Hospital Clinical Trials Center, Seoul, Korea, Republic of

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

Phase 1

Completed

Conditions: Hypertension

Interventions: Drug: Telmisartan
Drug: Amlodipine
Drug: Chlorthalidone

First Posted Date: 2014-06-02

Last Posted Date: 2014-11-19

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 66

Registration Number: NCT02152969

Locations: 🇰🇷
The Catholic University of Korea Seoul St.Mary's Hospital, Seoul, Korea, Republic of

Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Rosuvastatin, Metformin, YH14755
Drug: YH14755

First Posted Date: 2014-04-29

Last Posted Date: 2014-10-09

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 56

Registration Number: NCT02125227

Locations: 🇰🇷
Chonbuk National University Hospital, Jeonju-si, Jeollabuk-do, Korea, Republic of

A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer

Phase 1

Completed

Conditions: Healthy Volunteer

Interventions: Drug: Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg)

First Posted Date: 2013-11-25

Last Posted Date: 2013-11-25

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 48

Registration Number: NCT01992601

Locations: 🇰🇷
Severance Hospital, Yonsei University, Seoul, Korea, Republic of

PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

Phase 1

Completed

Conditions: Dyslipidemia & Hypertension

Interventions: Drug: Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC

First Posted Date: 2013-11-05

Last Posted Date: 2013-11-05

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 185

Registration Number: NCT01975961

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: YH4808
Drug: Nexium
Drug: Amoxicillin
Drug: clarithromycin

First Posted Date: 2013-08-13

Last Posted Date: 2013-12-03

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 95

Registration Number: NCT01921647

Locations: 🇰🇷
Yonsei University Severance Hospital, Seoul, Korea, Republic of

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Phase 3

Completed

Conditions: Hyperlipidemia
Hypertension

Interventions: Drug: YH16410 placebo
Drug: YH16410
Drug: Rosuvastatin
Drug: Telmisartan
Drug: Rosuvastatin placebo
Drug: Telmisartan placebo

First Posted Date: 2013-08-02

Last Posted Date: 2014-07-08

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 210

Registration Number: NCT01914432

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: YH4808
Drug: Diclofenac
Drug: YH4808+Diclofenac

First Posted Date: 2013-06-12

Last Posted Date: 2014-01-01

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 49

Registration Number: NCT01876615

Locations: 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: YH12852
Drug: Prucalopride

First Posted Date: 2013-06-06

Last Posted Date: 2015-05-08

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 127

Registration Number: NCT01870674

Locations: 🇰🇷
Inje Busan Paik hospital, Busan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy